ADAMTS13 and autoimmune disease: To correctly diagnose such iTTP patients, clinical attention is attracted towards a novel biomarker: an open ADAMTS13 conformation, as conformationally altered self-antigens are also observed in other autoimmune diseases [42,43,44,45,46,47].